FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2969470858> ?p ?o ?g. }

• W2969470858 endingPage "1527" @default.
• W2969470858 startingPage "1518" @default.
• W2969470858 abstract "Patients with diabetes mellitus (DM) have worse outcomes after percutaneous coronary intervention (PCI). Recent evidences suggest a differential impact of insulin-treated and noninsulin-treated DM on prognosis. We evaluated the clinical outcome of diabetic patients after PCI with polymer-free biolimus-eluting stent from the RUDI-FREE Registry, investigating a possible different prognostic impact of insulin-treated and noninsulin-treated DM. A total of 1,104 consecutive patients who underwent PCI with polymer-free biolimus-eluting stent, enrolled in the RUDI-FREE observational, multicenter, single-arm registry, were stratified by diabetic status; diabetic population was further divided on the basis of insulin treatment. Primary end points of the study were target lesion failure (TLF; composite of cardiac death, target vessel myocardial infarction, target lesion revascularization) and major adverse cardiac and cerebrovascular events (composite of cardiac death, stroke, and myocardial infarction). Multiple ischemic adverse events were also single-handedly considered as secondary end points. At 1 year, TLF was significantly higher in the diabetic cohort, as compared with nondiabetic patients (6.0% vs 3.1%, p 0.022). None of the end points resulted significantly different between nondiabetics and noninsulin-treated diabetic patients. Divergently, compared with nondiabetic, insulin-treated diabetic patients faced significant higher rates of TLF (10.8% vs 3.1%, p 0.003), major adverse cardiac and cerebrovascular events (10.8% vs 3.4%, p 0.004), and of most of the analyzed adverse events. In conclusion, patients with DM had a higher risk of TLF compared with nondiabetics; nonetheless, the worse outcome of the diabetic population seems to be driven by the insulin-treated diabetic subpopulation. This finding suggests a different risk profile of insulin-treated and noninsulin-treated diabetic patients in the modern era of PCI. Patients with diabetes mellitus (DM) have worse outcomes after percutaneous coronary intervention (PCI). Recent evidences suggest a differential impact of insulin-treated and noninsulin-treated DM on prognosis. We evaluated the clinical outcome of diabetic patients after PCI with polymer-free biolimus-eluting stent from the RUDI-FREE Registry, investigating a possible different prognostic impact of insulin-treated and noninsulin-treated DM. A total of 1,104 consecutive patients who underwent PCI with polymer-free biolimus-eluting stent, enrolled in the RUDI-FREE observational, multicenter, single-arm registry, were stratified by diabetic status; diabetic population was further divided on the basis of insulin treatment. Primary end points of the study were target lesion failure (TLF; composite of cardiac death, target vessel myocardial infarction, target lesion revascularization) and major adverse cardiac and cerebrovascular events (composite of cardiac death, stroke, and myocardial infarction). Multiple ischemic adverse events were also single-handedly considered as secondary end points. At 1 year, TLF was significantly higher in the diabetic cohort, as compared with nondiabetic patients (6.0% vs 3.1%, p 0.022). None of the end points resulted significantly different between nondiabetics and noninsulin-treated diabetic patients. Divergently, compared with nondiabetic, insulin-treated diabetic patients faced significant higher rates of TLF (10.8% vs 3.1%, p 0.003), major adverse cardiac and cerebrovascular events (10.8% vs 3.4%, p 0.004), and of most of the analyzed adverse events. In conclusion, patients with DM had a higher risk of TLF compared with nondiabetics; nonetheless, the worse outcome of the diabetic population seems to be driven by the insulin-treated diabetic subpopulation. This finding suggests a different risk profile of insulin-treated and noninsulin-treated diabetic patients in the modern era of PCI." @default.
• W2969470858 created "2019-08-29" @default.
• W2969470858 creator A5004101295 @default.
• W2969470858 creator A5004677044 @default.
• W2969470858 creator A5012665930 @default.
• W2969470858 creator A5018324773 @default.
• W2969470858 creator A5025451377 @default.
• W2969470858 creator A5029793091 @default.
• W2969470858 creator A5033705412 @default.
• W2969470858 creator A5037881065 @default.
• W2969470858 creator A5040442743 @default.
• W2969470858 creator A5055684454 @default.
• W2969470858 creator A5057508716 @default.
• W2969470858 creator A5058857515 @default.
• W2969470858 creator A5061341805 @default.
• W2969470858 creator A5063575585 @default.
• W2969470858 creator A5063939893 @default.
• W2969470858 creator A5065226508 @default.
• W2969470858 creator A5068467398 @default.
• W2969470858 creator A5071506939 @default.
• W2969470858 creator A5076921603 @default.
• W2969470858 creator A5080873579 @default.
• W2969470858 creator A5090353733 @default.
• W2969470858 date "2019-11-01" @default.
• W2969470858 modified "2023-09-26" @default.
• W2969470858 title "Impact of Insulin-Treated and Noninsulin-Treated Diabetes Mellitus in All-Comer Patients Undergoing Percutaneous Coronary Interventions With Polymer-Free Biolimus-Eluting Stent (from the RUDI-FREE Registry)" @default.
• W2969470858 cites W1833525648 @default.
• W2969470858 cites W1969081971 @default.
• W2969470858 cites W1988879418 @default.
• W2969470858 cites W2008098527 @default.
• W2969470858 cites W2049120615 @default.
• W2969470858 cites W2112494872 @default.
• W2969470858 cites W2133452492 @default.
• W2969470858 cites W2141087431 @default.
• W2969470858 cites W2145999403 @default.
• W2969470858 cites W2147673265 @default.
• W2969470858 cites W2149825099 @default.
• W2969470858 cites W2168730831 @default.
• W2969470858 cites W2169241798 @default.
• W2969470858 cites W2194429015 @default.
• W2969470858 cites W2342315189 @default.
• W2969470858 cites W2515533568 @default.
• W2969470858 cites W2542456933 @default.
• W2969470858 cites W2799777685 @default.
• W2969470858 cites W2804073465 @default.
• W2969470858 cites W2888543854 @default.
• W2969470858 cites W2889726323 @default.
• W2969470858 cites W2893091384 @default.
• W2969470858 cites W2903695177 @default.
• W2969470858 cites W2916912835 @default.
• W2969470858 cites W2918557729 @default.
• W2969470858 cites W2921847080 @default.
• W2969470858 cites W2941206839 @default.
• W2969470858 cites W3171237122 @default.
• W2969470858 cites W34784395 @default.
• W2969470858 cites W4241883936 @default.
• W2969470858 cites W4247546790 @default.
• W2969470858 cites W95957117 @default.
• W2969470858 doi "https://doi.org/10.1016/j.amjcard.2019.08.015" @default.
• W2969470858 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31547997" @default.
• W2969470858 hasPublicationYear "2019" @default.
• W2969470858 type Work @default.
• W2969470858 sameAs 2969470858 @default.
• W2969470858 citedByCount "12" @default.
• W2969470858 countsByYear W29694708582020 @default.
• W2969470858 countsByYear W29694708582021 @default.
• W2969470858 countsByYear W29694708582022 @default.
• W2969470858 countsByYear W29694708582023 @default.
• W2969470858 crossrefType "journal-article" @default.
• W2969470858 hasAuthorship W2969470858A5004101295 @default.
• W2969470858 hasAuthorship W2969470858A5004677044 @default.
• W2969470858 hasAuthorship W2969470858A5012665930 @default.
• W2969470858 hasAuthorship W2969470858A5018324773 @default.
• W2969470858 hasAuthorship W2969470858A5025451377 @default.
• W2969470858 hasAuthorship W2969470858A5029793091 @default.
• W2969470858 hasAuthorship W2969470858A5033705412 @default.
• W2969470858 hasAuthorship W2969470858A5037881065 @default.
• W2969470858 hasAuthorship W2969470858A5040442743 @default.
• W2969470858 hasAuthorship W2969470858A5055684454 @default.
• W2969470858 hasAuthorship W2969470858A5057508716 @default.
• W2969470858 hasAuthorship W2969470858A5058857515 @default.
• W2969470858 hasAuthorship W2969470858A5061341805 @default.
• W2969470858 hasAuthorship W2969470858A5063575585 @default.
• W2969470858 hasAuthorship W2969470858A5063939893 @default.
• W2969470858 hasAuthorship W2969470858A5065226508 @default.
• W2969470858 hasAuthorship W2969470858A5068467398 @default.
• W2969470858 hasAuthorship W2969470858A5071506939 @default.
• W2969470858 hasAuthorship W2969470858A5076921603 @default.
• W2969470858 hasAuthorship W2969470858A5080873579 @default.
• W2969470858 hasAuthorship W2969470858A5090353733 @default.
• W2969470858 hasConcept C126322002 @default.
• W2969470858 hasConcept C127413603 @default.
• W2969470858 hasConcept C134018914 @default.
• W2969470858 hasConcept C141071460 @default.
• W2969470858 hasConcept C164705383 @default.
• W2969470858 hasConcept C197934379 @default.
• W2969470858 hasConcept C2778583881 @default.
• W2969470858 hasConcept C2779464278 @default.

• next